Previous Article | Next Article 
Journal of Virology, February 2000, p. 1623-1631, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Biochemical Consequences of a Mutation That
Controls the Cholesterol Dependence of Semliki Forest Virus
Fusion
Prodyot K.
Chatterjee,
Malini
Vashishtha, and
Margaret
Kielian*
Department of Cell Biology, Albert Einstein
College of Medicine, Bronx, New York 10461
Received 16 September 1999/Accepted 11 November 1999
 |
ABSTRACT |
The enveloped alphavirus Semliki Forest virus (SFV) infects cells
via a low-pH-triggered membrane fusion reaction that requires cholesterol and sphingolipid in the target membrane.
Cholesterol-depleted insect cells are highly resistant to alphavirus
infection and were used to select srf-3, an SFV mutant that
is ~100-fold less cholesterol dependent for infection due to a single
amino acid change in the E1 spike subunit, proline 226 to serine.
Sensitive lipid-mixing assays here demonstrated that the in vitro
fusion of srf-3 and wild-type (wt) virus with
cholesterol-containing liposomes had comparable kinetics, activation
energies, and sphingolipid dependence. In contrast, srf-3
fusion with sterol-free liposomes was significantly more efficient than
that of wt virus. Thus, the srf-3 mutation does not affect
its general fusion properties with purified lipid bilayers but causes a
marked and specific reduction in cholesterol dependence. Upon exposure
to low pH, the E1 spike subunit undergoes distinct conformational
changes, resulting in the exposure of an acid conformation-specific
epitope and formation of an E1 homotrimer. These conformational changes were strongly cholesterol and sphingolipid dependent for wt SFV and
strikingly less cholesterol dependent for srf-3. Our
results thus demonstrate the functional importance of fusogenic E1
conformational changes in the control of SFV cholesterol dependence.
 |
INTRODUCTION |
In spite of long-standing interest
in the role of cholesterol, its functions in eukaryotic cells are not
well understood. Cholesterol is essential for mammalian cells and is
believed to be required as both a bulk component of cell membranes and
a specific modulator of membrane protein function (reviewed in
references 40 and 57). Increased
evidence for the importance of cholesterol has come from recent studies
demonstrating that cholesterol is a covalent adduct critical for the
function of embryonic signalling molecules (46) and that
cholesterol is involved in the formation and function of caveolae and
clathrin-coated vesicles, key membrane specializations in mammalian
cells (5, 47, 52). A well-defined example of a membrane
protein with a specific functional requirement for cholesterol is the
Semliki Forest virus (SFV) spike glycoprotein, which requires
cholesterol to mediate the fusion of the virus membrane with a target
membrane. Membrane fusion is the mechanism used by enveloped viruses to
infect cells and also plays a key role in such important cellular
processes as endocytosis, exocytosis, and cell-cell fusion
(22). The SFV spike protein thus illustrates the potential
importance of specific membrane lipids in the function of a fusion
protein and represents a model for cholesterol-membrane protein interactions.
SFV is a member of the alphaviruses, enveloped RNA viruses that infect
cells by using receptor-mediated endocytosis and low-pH-mediated fusion
of the virus membrane with that of the endosome (reviewed in references
19, 25, 26, and 51). SFV fusion
with liposomes has a striking requirement for two specific lipids in
the liposome membrane, cholesterol and sphingolipid. Optimal fusion
requires about one molecule of cholesterol per two molecules of
phospholipid (33 mol%) (55) and is specific for sterols
containing the 3
-hydroxyl group (29). In contrast,
optimal fusion requires only ~2 to 5 mol% sphingolipid, of which
ceramide is the minimal sphingolipid structure that supports fusion
(38, 42).
Low pH triggers a series of conformational changes in the SFV spike
protein that lead to the fusion of the virus membrane with the target
membrane (reviewed in references 1, 25, 26, and
28). The virus spike proteins are trimers
(E1/E2/E3)3 of two type I transmembrane glycoproteins, E1
and E2 (each about 50 kDa), and a peripheral glycoprotein E3 (~10
kDa). The initial event in fusion appears to be the disruption of the
ight interaction between E2 and E1. The released E1 subunit
then undergoes distinct acid-dependent conformational changes whose
kinetics, biochemical properties, and sequence requirements correlate
with the virus fusion reaction both in vitro and in vivo. Previously
masked acid conformation-specific monoclonal antibody (MAb) binding
sites on E1 are exposed, and E1 forms a homotrimer (E1)3
that is trypsin resistant and highly stable. During fusion, E1
associates with the target membrane, presumably via membrane insertion
of a hydrophobic fusion peptide located between amino acids 79 and 97 of E1 (25, 32). A lag period is observed between the
completion of these E1 conformational changes and E1 membrane
insertion, and the initiation of membrane fusion, and it is believed to
reflect additional, as yet uncharacterized steps in the fusion reaction
(9).
While the cholesterol dependence of SFV fusion was first observed in
fusion experiments with liposomes, it has also been demonstrated in
vivo in studies of cholesterol-depleted C6/36 mosquito cells (36,
37, 45, 53). Sterol-depleted cells are about 5,000-fold more
resistant to primary infection than are control cells and are also less
efficient in the exit of newly synthesized virus. We used such depleted
cells to select srf-3 (for "sterol requirement in
function"), a mutant virus that grew more efficiently in the absence
of cholesterol (37, 53). srf-3 is increased about 100-fold in its ability to infect cells without cholesterol and about
500-fold in its ability to fuse with the depleted cell plasma membrane,
and it also shows more efficient exit from cells lacking cholesterol.
Sequence analysis showed that the srf-3 mutation is a change
of proline 226 to serine (P226S) within the E1 subunit. Studies of
Sindbis virus (SIN), another member of the alphaviruses, demonstrated
that SIN has comparable cholesterol requirements to those of wild-type
(wt) SFV and that mutations in the E1 226 region could similarly
increase SIN fusion and exit from sterol-depleted cells
(35).
From these studies, it was clear that the P226S mutation significantly
reduced the cholesterol dependence of SFV when assayed in the context
of sterol-depleted insect cells. However, cholesterol depletion could
also produce changes in membrane lipid composition, lipid distribution,
or other properties of the cell membrane that could affect its fusion
potential. Although the block in wt SFV fusion was reversed by addition
of cholesterol to the depleted cells, reversal required overnight
culture to redistribute the added cholesterol into the cell plasma
membrane (37, 45). Thus, clearly the decrease in
srf-3 cholesterol dependence observed in this complex
biological system could differ from its fusion properties with a
well-defined lipid bilayer. In addition, a key unresolved issue is the
mechanism by which the P226S mutation affects virus cholesterol
dependence. The mutation could act by making the virus a more efficient
overall fusogen, thus increasing its fusion capacity on a number of
target membranes including those without cholesterol. Alternatively,
the mutation might affect only the spike protein cholesterol
requirement, perhaps by affecting the acid-dependent conformational
changes in E1. It is also possible that srf-3 has
alterations in fusion steps downstream of the E1 conformational
changes, such as steps occuring during the lag period.
In the present study, we have characterized the properties of the P226S
mutation by using a defined liposome system. This in vitro system
enabled us to sensitively measure the fusion properties of
srf-3, to determine its overall dependence on both
cholesterol and sphingolipid, and to study its E1 conformational
changes. Our results demonstrate that while its overall fusion
properties were very similar to those of wt SFV, srf-3
showed a significant and specific increase in fusion activity with
sterol-deficient liposomes. This increased fusion was due to the
increased cholesterol independence of srf-3 E1
conformational changes, including acid-specific epitope exposure and E1 homotrimerization.
 |
MATERIALS AND METHODS |
Cells and viruses.
BHK-21 cells were maintained as
previously described (53) and used for virus propagation,
plaque titer determination, and infectivity experiments. C6/36 mosquito
cells were depleted of cholesterol by 4 to 15 passages in medium
containing lipoprotein-depleted fetal calf serum, as previously
described (53).
wt SFV was previously plaque purified from prototype wt virus obtained
from the Department of Virology, University of Helsinki, and has been
extensively characterized (20, 53). The srf-3 mutant was derived from this wt stock by successive passages on cholesterol-depleted C6/36 cells, as described in detail previously (53). Previous studies have demonstrated that
srf-3 has a decreased requirement for cellular cholesterol
for virus infection, fusion, and exit due to a single amino acid change
of E1 proline 226 to serine (35-37, 53).
Preparation of pyrene and radiolabeled viruses.
Pyrene-labeled viruses (wt SFV and srf-3) were prepared
using a slightly modified version of published procedures (9,
54). BHK-21 cells were cultured for 15 h in
850-cm2 roller bottles containing Dulbecco's modified
Eagle's medium supplemented with 100 U of penicillin per ml, 100 µg
of streptomycin per ml, 5% fetal calf serum, and 10% tryptose
phosphate broth. Cellular phospholipids were labeled by growth for
24 h in the presence of C16-pyrene (Molecular Probes,
Eugene, Oreg.) at a final concentration of 10 µg/ml. The cells were
then infected with wt SFV or srf-3 at a multiplicity of 5 PFU/cell, and the infection was continued for 24 h in the above
BHK growth medium without pyrene. The virus-containing medium was then
harvested, the cell debris was removed by centrifugation, and the
labeled virus was pelleted and resuspended in TN buffer (50 mM Tris,
100 mM NaCl [pH 7.4]). The virus was then purified by centrifugation on a discontinuous sucrose gradient (10 to 20%/25 to 50% sucrose [wt/wt] in TN buffer) (30). The virus band was harvested,
the virus protein concentration was determined (34), and
aliquots were snap-frozen in liquid nitrogen and stored at
80°C.
The pyrene excimer-to-monomer ratio was determined for each virus
preparation by exciting at 343 nm at 37°C and recording the emitted
fluorescence at 480 (excimer) and 398 nm (monomer) on an SLM-8000
fluorometer, as described below. The excimer-to-monomer ratios were
0.38 and 0.37 for wt SFV and srf-3, respectively. These
ratios are similar to those previously described for pyrene-labeled
preparations of wt SFV (9).
[
35S]methionine and [
35S]cysteine-labeled
wt or
srf-3 virus was prepared by growth in BHK cells, or in
cholesterol-depleted C6/36
cells (
srf-3 only)
(
53). Labeled viruses were purified by banding
on a
discontinuous sucrose gradient as described above. Radiolabeled
srf-3 prepared from cholesterol-depleted cells contained
both
intact virus and disrupted virus particles (
53).
Liposomes.
Large unilamellar vesicles were prepared by
freezing-thawing and extrusion using a published procedure
(15) with some modifications. Lipid mixtures were washed
with chloroform and t-butanol in a rotary evaporator,
lyophilized for at least 90 min, hydrated in buffer, and vortexed with
glass beads. The suspensions were subjected to 10 cycles of
freezing-thawing and extruded 21 times through two stacked
polycarbonate filters (pore size, 0.2 µm) using a Liposofast
mini-extruder (Avestin, Ottawa, Canada). Lipids were hydrated in MES
buffer (20 mM morpholine ethanesulfonic acid [MES] and 130 mM NaCl
[pH 7.0] with or without 0.2% bovine serum albumin) for assays of E1
conformational changes or HNE buffer (5 mM HEPES, 150 mM NaCl, 0.1 mM
EDTA [pH 7.0]) for fusion studies. Complete liposomes contained a
1:1:1:1.5 molar ratio of phosphatidylcholine (PC; from egg yolk),
phosphatidylethanolamine (PE; prepared from egg PC by
transphosphatidylation), sphingomyelin (Sph; from bovine brain), and
cholesterol. Sterol-free liposomes had a PC/PE/Sph molar ratio of
1:1:1. Sphingolipid-free liposomes had a PC/PE/cholesterol molar ratio
of 1:1:1. Liposomes without sphingolipid and sterol contained 1:1
PC/PE. All phospholipids were purchased from Avanti Polar Lipids
(Alabaster, Ala.), and cholesterol was purchased from Steraloids Inc.
(Wilton, N.H.). Phospholipid quantitation was performed as described
previously (39).
Fusion assay.
Lipid mixing during SFV-liposome fusion was
assayed by monitoring the decrease in virus pyrene excimer fluorescence
(9, 54). Each assay mixture (2 ml) contained purified
pyrene-labeled virus (0.6 µM phospholipid as calculated from a
phospholipid/protein ratio of 0.45 µmol/µg) and 200 to 800 µM
liposomes of the indicated lipid composition. The mixtures were stirred
continuously in a thermostatted cuvette at the indicated temperature.
Fusion was triggered by the addition of a pretitrated volume of 0.3 M
MES (pH 4.8) to give a final pH of 5.5. Pyrene excimer fluorescence was
measured in an SLM-8000 fluorometer upgraded to SLM-8100 software (SLM-Aminco, Urbana, Ill.), using excitation and emission wavelengths of 343 and 480 nm, respectively, in the presence of a 470-nm cutoff filter in the emission beam. The 0% fusion level was set at the initial excimer fluorescence, and the 100% fusion level was set at the
background intensity of the target liposomes at the concentration used
in the reaction.
Sensitivity of virus infection to inhibition by
NH4Cl.
The sensitivity of infection by wt SFV and
srf-3 to inhibition by NH4Cl was assayed as a
marker of the pH dependence of virus fusion, as previously described
(20). BHK cells in 24-well trays were preincubated for 15 min with the indicated concentration of NH4Cl and then
infected for 90 min with virus at a multiplicity of 1 PFU/cell in the
presence of the indicated concentrations of NH4Cl.
Virus-specific RNA synthesis was quantitated by labeling for 3.5 h
with [3H]uridine in the presence of 2 µg of actinomycin
D per ml and 20 mM NH4Cl to prevent secondary infection.
Analysis of low pH-dependent conformational changes in virus
spike proteins.
To assess conformational changes in the virus
spike proteins, [35S]methionine- and
[35S]cysteine-labeled virus was mixed with 800 µM
liposomes of the appropriate composition, treated at the indicated pH,
and returned to neutral pH. The exposure of acid conformation-specific
epitopes was determined by immunoprecipitation with E1a-1, a previously characterized E1 acid conformation-specific MAb (27).
Formation of the E1 homotrimer was evaluated by incubating samples in
sodium dodecyl sulfate (SDS)-gel sample buffer for 3 min at 30°C and then analyzing them by SDS-polyacrylamide gel electrophoresis (PAGE)
(28, 54). Quantitation of SDS-gel assays was performed by
PhosphorImager analysis with Image Quant v.1.2 software (Molecular Dynamics, Sunnyvale, Calif.).
 |
RESULTS |
Fusion of wt SFV and srf-3 with cholesterol-containing
membranes in vitro.
The low-pH-induced fusion of wt SFV with cell
plasma membranes is highly cholesterol dependent, with fusion ~4 to 5 logs lower on depleted cells than on control cells (35, 53).
While srf-3 is increased about 1,000-fold in its ability to
fuse with depleted cells, it still shows maximal fusion on cells
containing cholesterol, with approximately a 100-fold difference
between the two cell types (35, 53). To characterize
srf-3 fusion in vitro with cholesterol-containing and
-depleted membranes, we reasoned that we would need to use a highly
sensitive fusion assay that might be capable of detecting
srf-3 fusion with sterol-free membranes. We therefore used a
previously described lipid-mixing assay based on the fusion of
pyrene-labeled virus with unlabeled liposomes (9, 54). This
assay is based on the biosynthetic labeling of cells with pyrene fatty
acids, which are incorporated into phospholipids in the cell plasma
membrane and acquired by the virus during budding. At high
concentrations, pyrene displays a characteristic excimer peak at 480 nm, which is lost when the pyrene label is diluted during virus fusion.
The loss of excimer fluorescence can be monitored in real time and is a
sensitive fusion assay that shows little nonspecific exchange of the
fluorescent label (9, 54). We prepared pyrene-labeled wt SFV
and srf-3 and determined that both virus preparations had
comparable ratios of pyrene excimer to monomer fluorescence, indicating
comparable densities of pyrene fluorophore in the virus membranes. The
fusion of these virus preparations was then characterized using
"complete" liposomes (PC/PE/Sph/cholesterol, 1:1:1:1.5) that
contain both cholesterol and sphingolipid and support efficient wt SFV
fusion (9, 55). Fusion was initiated by adjusting the
virus-liposome mixture to pH 5.5 and plotted as the percentage of
maximal pyrene dilution. Real-time fluorescence recordings of fusion
reactions with wt SFV and srf-3 at incubation temperatures
of 37 and 20°C are shown (Fig. 1A).
Both viruses fused rapidly and efficiently and showed comparable rates
and extents of fusion at both 37 and 20°C. A series of fusion
experiments were performed at temperatures ranging from 5 to 30°C,
and the initial rates of fusion were plotted against the reciprocal of
the absolute temperature in an Arrhenius diagram (Fig. 1B). As
previously described, a slow rate of SFV fusion occurred even at
temperatures as low as 5°C (9, 55). The Arrhenius diagrams
of wt SFV and srf-3 were indistinguishable, with similar
straight lines and slopes for both viruses. Thus, wt SFV and
srf-3 have similar, constant activation energies for fusion
throughout the temperature range. These results imply that the
rate-limiting steps of the overall fusion process are comparable for wt
SFV and srf-3, suggestive of similar fusion mechanisms with
complete liposomes. We also quantitated the low-pH-dependent association of radiolabeled wt SFV and srf-3 with complete
liposomes, using a gradient flotation assay that measures both virus
binding and fusion (29). Virus-membrane association was
comparable for wt SFV and srf-3 when assayed after a 5-min
treatment at pH 5.5 and 37°C (data not shown). Thus, the overall
properties of fusion with cholesterol-containing membranes are
conserved between wt SFV and the srf-3 mutant.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Fusion of wt SFV and srf-3 with complete
liposomes. (A) Real-time fluorescence recordings of the fusion of
pyrene-labeled wt or srf-3 virus (0.6 µM) with unlabeled
complete liposomes (200 µM). Samples were preequilibrated for 3 to 5 min at the indicated temperature in buffer at pH 7.0. At time zero, the
mixture was adjusted to pH 5.5 (B) Arrhenius plot of the initial rate
of fusion (the slope of the steepest part of the curve) for wt SFV and
srf-3 at various temperatures. Each point is the average of
two independent determinations.
|
|
Lipid dependence of wt SFV and srf-3 fusion.
To
compare the lipid dependence of wt SFV and srf-3 fusion,
liposomes were prepared in the absence of either cholesterol
(PC/PE/Sph, 1:1:1) or sphingolipid (PC/PE/cholesterol, 1:1:1). Since wt
virus is rapidly acid inactivated at 37°C (9), fusion
assays with deficient liposomes were performed at either 20 or 25°C
to increase the potential time available for fusion with these
suboptimal liposomes. As demonstrated previously (9) and
above, fusion at these temperatures occurs by a similar mechanism to
that at 37°C and mediates efficient virus infection. To maximize the
possibility of virus fusion with the liposome membrane, the liposome
concentration was also increased from 200 to 800 µM. While the higher
liposome concentration increases the likelihood of a productive
interaction between virus and target membrane (9), it also
increases the light scattering in the reaction, precluding the use of
concentrations above ~800 µM. Pilot experiments demonstrated that
the initial rate of fusion of wt SFV or srf-3 with complete
liposomes was increased about threefold using 800 µM liposomes
compared to 200 µM liposomes (data not shown). Using these
modifications, the fusion characteristics of wt SFV and
srf-3 were compared using sterol-free liposomes at 25°C
and pH 5.5 (Fig. 2). wt virus, as predicted, showed little fusion even in this optimized assay, with
final extents of about 5 to 7%. In contrast, srf-3
consistently showed an increased level of fusion with the sterol-free
liposomes, with fusion extents of about 10 to 15%. Thus, although
srf-3 fusion in the absence of cholesterol was much less
efficient than with complete liposomes, a significant increase in
fusion compared to wt SFV was observed. This is the first evidence for
decreased cholesterol dependence in srf-3 using a defined
lipid bilayer and indicates that the decreased cholesterol requirement
for srf-3 fusion is not dependent on the lipid composition
or membrane properties of sterol-depleted mosquito cells but can be
replicated in vitro.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Fusion of wt SFV and srf-3 with
cholesterol-free liposomes. Real-time fluorescence recordings of the
fusion of pyrene-labeled wt or srf-3 virus (0.6 µM) with
unlabeled sterol-free liposomes (800 µM) are shown. Samples were
preequilibriated for 5 min at 25°C, and the pH was adjusted to 5.5 at
time zero. This is a representative example of four experiments.
|
|
We next examined the sphingolipid dependence for fusion of both wt SFV
and
srf-3. Fusion experiments were performed in parallel
with complete, sterol-free, or sphingolipid-free liposomes at
20°C
using liposome concentrations of 800 µM. The ratio of the
final
extent of fusion of
srf-3 versus wt SFV was plotted for
each
liposome type (Fig.
3). Both viruses
showed comparable fusion
extents with complete liposomes (ratio ~1)
and sphingolipid-free
liposomes (ratio, ~1.2). In contrast, and in
agreement with the
results in Fig.
2, on average
srf-3
fusion with sterol-free liposomes
was ca. twofold higher than that of
wt virus. The final fusion
extents in the four experiments in this
figure varied somewhat
between experiments, apparently due to variation
between different
preparations of liposomes, but the ratios of fusion
between
srf-3 and wt SFV were quite consistent.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Lipid dependence of wt SFV and srf-3 liposome
fusion. Pyrene-labeled wt or srf-3 virus (0.6 µM) was
mixed with unlabeled liposomes (800 µM) composed of
PC-PE-Sph-cholesterol (complete), PC-PE-Sph ( sterol), or
PC-PE-cholesterol ( sph). Samples were preequlibriated for 5 min at
20°C, the pH was adjusted to pH 5.5, and the final extents of fusion
were measured after 60 s at 20°C. Data were plotted as the ratio
of srf-3 to wt SFV fusion for each liposome type. The graph
represents the average of four independent determinations for each
virus, and the bars show the standard deviation.
|
|
Comparison of the initial rates of
srf-3 fusion with
sterol-free and cholesterol-containing liposomes showed that the rate
was about eightfold slower in the absence of cholesterol (data
not
shown). This result suggests that the final extent of
srf-3 fusion is lower with sterol-free than with cholesterol-containing
liposomes because the slower fusion rate alters the equilibrium
between
acid-dependent fusion and acid inactivation (
9). It
is known
that inactivation of virus fusion activity occurs upon
exposure of
virus to acidic pH in the absence of a fusion-competant
membrane and
has kinetics slower than those of fusion (
9).
No reliable
comparison could be made to the rate of wt virus fusion
with
sterol-free liposomes since this rate was below the limit
of accurate
detection in our assay
system.
pH dependence of wt SFV and srf-3 infection.
Taken
together, the above data indicated that srf-3 was less
cholesterol dependent for fusion than wt SFV but had a similar overall
fusion mechanism and sphingolipid dependence. In addition to the lipid
requirements for fusion, a critical parameter of the SFV fusion
reaction is its pH dependence. It was important to determine if the
srf-3 phenotype involved a change in the pH dependence of
fusion, a parameter that can be sensitively measured in vivo. During
virus uptake into host cells, fusion of SFV takes place in the endosome
and results in virus infection. The pH dependence of this intracellular
fusion event can be assessed by measuring its sensitivity to inhibition
by a variety of agents that act to raise the pH of the endosome above
the threshold required for fusion (31). For example, this in
vivo assay was used to demonstrate differences in the fusion thresholds
of wt SFV, a strain of SIN, and a fusion mutant of SFV (20,
21). BHK cells were infected with wt SFV and srf-3 in
the presence of various concentrations of the lysosomotropic weak base
NH4Cl, and virus infection was quantitated by monitoring
the incorporation of [3H]uridine into viral RNA (20,
31). The NH4Cl sensitivities of wt SFV and
srf-3 infection were similar, displaying half-maximal inhibition at about ~8 mM NH4Cl (Fig.
4). This result suggested that the pH
dependence of fusion within the endosome was similar for both viruses.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Sensitivity of infection by wt SFV and srf-3
to inhibition by NH4Cl. BHK cells were pretreated for 15 min with the indicated concentrations of NH4Cl and infected
with wt SFV or srf-3 at 1 PFU/cell for 90 min in the
continued presence of NH4Cl. Infection was then quantitated
by determining the incorporation of [3H]uridine into
viral RNA in the presence of 20 mM NH4Cl to prevent
secondary infection. [3H]uridine incorporation was
expressed as a percentage of control incorporation in the absence of
NH4Cl, with the background incorporation obtained in
uninfected cells subtracted from all points. The graph represents the
mean of two separate experiments.
|
|
Cholesterol dependence of E1 conformational changes in wt SFV and
srf-3.
We hypothesized that the increased ability of
srf-3 to fuse with cholesterol-depleted membranes is due to
an increase in the cholesterol independence of a sterol-requiring step
in fusion. To test our hypothesis, we monitored acid
conformation-specific epitope exposure and E1 homotrimer formation, two
distinct acid-induced conformational changes that are enhanced by
cholesterol for the wt E1 protein (14, 26, 32). Since
cholesterol affects the rate of these E1 conformational changes, their
kinetics were compared in the presence of liposomes with or without
cholesterol, using conditions of suboptimal pH and temperature to slow
the reaction.
To assay acid epitope exposure, radiolabeled wt SFV and
srf-3 were mixed with cholesterol-containing or sterol-free
liposomes
and treated at pH 5.8 for various times at 4°C. Samples
were returned
to neutral pH and immunoprecipitated with MAb E1a-1, a
MAb that
specifically detects the acid conformation of E1 (
1,
27),
or with a rabbit polyclonal anti-spike antibody that
quantitatively
precipitates the total E1 present in the reaction
mixture. When
exposed to low pH in the presence of cholesterol
liposomes, wt
E1 rapidly converts to a form that reacts with the MAb
(Fig.
5A).
Conversion after 1 min of
low-pH treatment at 4°C was ~98% of
that obtained after similar
treatment for 1 min at 37°C. Conversion
was efficient, with the
maximal MAb E1a-1 precipitation being
~70% of the total E1. In
comparison, the efficiency of
srf-3 E1
conversion after 1 min of treatment at 4°C in the presence of
cholesterol liposomes was
~76% of that obtained at 37°C, and the
maximal E1a-1 precipitation
was ~70% of the total E1 (Fig.
5B).
Thus, the efficiency of the E1
conformational change under cholesterol-containing
control conditions
was similar for wt SFV and
srf-3. However,
when the pH
treatment was performed in the presence of sterol-free
liposomes,
almost no wt E1 became immunoreactive after 30 s of
pH treatment
(Fig.
5A). The conversion of wt E1 slowly increased
with time of pH
treatment, but even after 3 min of pH treatment,
it was considerably
below that obtained with complete liposomes.
In contrast,
srf-3 conversion in the absence of sterol was much
more
efficient than that of wt virus throughout the entire period
(Fig.
5B).
Conversion was quantitated by PhosphorImager analysis
and plotted for
each time point as the ratio of E1 conversion
with sterol-free
liposomes to E1 conversion with complete liposomes
(Fig.
5C). Even
after 3 min of low-pH treatment with sterol-free
liposomes, wt E1
showed a conversion ratio of only ~0.18 of that
obtained with
cholesterol liposomes. The
srf-3 E1 conformational
change
was much less cholesterol dependent, with conversion in
sterol-free
liposome samples ranging from ~0.6 to 0.9 of that
obtained with
cholesterol liposomes. Similar results were obtained
when this
experiment was performed at 20°C, although the magnitude
of the wt
SFV difference with and without sterol was smaller than
that at 4°C
(data not shown).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
Cholesterol dependence of E1 acid conformation-specific
epitope exposure in wt SFV and srf-3. (A and B)
[35S]methionine- and [35S]cysteine-labeled
wt SFV (A) or srf-3 (B) was mixed with either complete,
cholesterol-containing liposomes or liposomes without sterol and
treated at pH 5.8 for the indicated times at 4°C unless otherwise
indicated. The samples were then adjusted to neutral pH, solubilized in
buffer containing 1% Triton X-100, and immunoprecipitated with an acid
conformation-specific MAb to the E1 subunit (E1a-1), a rabbit
polyclonal antibody to the SFV spike protein (poly), or an unrelated
MAb (NI). Immunoprecipitates were analyzed by SDS-PAGE and
fluorography. (C) E1 precipitated by MAb E1a-1 was quantitated by
PhosphorImager analysis and plotted for each time point as the
ratio of the E1 converted in the presence of sterol-free liposomes
compared to the E1 converted in the presence of complete liposomes. The
graph represents the mean of two independent experiments.
|
|
The cholesterol dependence of E1 homotrimer formation was similarly
compared between wt SFV and
srf-3, using incubation at
pH
5.8 and 20°C in the presence of complete or sterol-free liposomes
(
14,
54). The samples were analyzed by SDS-PAGE under
solubilization
conditions that preserve the homotrimer (Fig.
6A and B). In the
presence of cholesterol
liposomes, both viruses efficiently produced
E1 homotrimer, with
maximal levels in two experiments ranging
from 61 to 68% of the total
E1 for wt SFV and 53 to 78% for
srf-3.
The pH dependence of
homotrimer formation was assayed by treating
virus plus complete
liposomes at various pH values and was comparable
for wt SFV and
srf-3 (data not shown), again indicating that the
srf-3 mutation does not affect the virus pH dependence.
However,
the sterol dependence of wt SFV versus
srf-3
homotrimer formation
showed a clear difference (Fig.
6A and B). The
ratio of the homotrimer
obtained with sterol-free liposomes to the
homotrimer obtained
with complete liposomes was determined for each
virus at the various
time points (Fig.
6C). wt E1 homotrimer formation
in the sterol-free
samples was much lower than that in the cholesterol
liposome samples,
with ratios ranging from an initial level of ~0.1
to a level of
~0.6 with longer incubation. In contrast, the
efficiency of homotrimer
formation with
srf-3 was comparable
with or without sterol, with
ratios ranging from 0.7 to 1.0. Similar
results were obtained
when this experiment was performed at 4°C (data
not shown). Taken
together, these data indicate that two distinct
acid-dependent
conformational changes in E1, epitope exposure and
homotrimerization,
were less cholesterol dependent in the
srf-3 mutant.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 6.
Cholesterol dependence of E1 homotrimer formation in wt
SFV and srf-3. (A and B) [35S]methionine- and
[35S]cysteine-labeled wt SFV (A) or srf-3 (B)
was mixed with either complete, cholesterol-containing liposomes or
liposomes without sterol and treated at pH 5.8 for the indicated times
at 20°C unless otherwise indicated. The samples were then adjusted to
neutral pH, solubilized in SDS sample buffer for 3 min at 30°C, and
analyzed by SDS-PAGE. (C) Homotrimeric E1 was quantitated by
PhosphorImager analysis and plotted for each time point as the ratio of
homotrimer in the presence of sterol-free liposomes compared to
homotrimer in the presence of complete liposomes. The graph represents
the mean of four independent experiments.
|
|
The alphavirus lipid bilayer is derived from the host cell during virus
budding from the plasma membrane. The radiolabeled
viruses used in the
above experiments were produced in BHK cells
and thus contained
cholesterol in the virus membranes (
25).
srf-3,
unlike wt virus, can be propagated in sterol-depleted cells.
Previous
experiments demonstrated that
srf-3 virus produced in
the
absence of cholesterol is viable and morphologically normal
although
significantly less stable to centrifugal shear force
than virus
propagated in cholesterol-containing cells (
53).
We
investigated whether virus membrane cholesterol plays a role
in E1
conformational changes by assaying radiolabeled
srf-3
produced
in cholesterol-depleted C6/36 cells. Similar to the results
with
srf-3 produced in BHK cells, conversion of this
sterol-deficient
srf-3 to reactivity with MAb E1a-1 was much
less cholesterol dependent
than for wt virus (data not shown). Thus, it
appears that the
conformational changes in
srf-3 E1 are
relatively cholesterol
independent regardless of the presence or
absence of cholesterol
in the virus membrane. This is in keeping with
the specific requirement
for cholesterol in the target membrane during
virus fusion (
25,
26).
Sphingolipid dependence of E1 conformational changes in wt SFV and
srf-3.
To test the importance of sphingolipid in the
conformational changes in the wt and srf-3 E1 proteins, we
made use of a system recently described by Corver (14).
Radiolabeled wt or srf-3 virus was treated at pH 5.8 and
20°C in the presence of either PC-PE-Sph or PC-PE liposomes. E1
homotrimerization was assayed by SDS-PAGE. Both liposome types are
cholesterol free and do not support the maximum efficiency of E1
conformational changes, but, similar to the results obtained by Corver
(14), this assay demonstrated a striking enhancement of wt
E1 homotrimerization by sphingolipid (Fig.
7). The relative sphingolipid dependence
of wt SFV and srf-3 was compared by plotting the ratio of
homotrimer obtained without sphingolipid to homotrimer obtained with
sphingolipid at each time point (Fig. 7). In the absence of
sphingolipid, E1 homotrimer formation by either wt SFV or
srf-3 was inefficient, with ratios below 0.2 for both
viruses. Acid conformation-specific epitope exposure was assayed using
the same liposome system, and a similar, strong sphingolipid dependence
for both viruses was observed (data not shown). Thus, the
srf-3 mutation does not significantly affect the
sphingolipid dependence of the E1 conformational changes, in keeping
with the similar sphingolipid dependence of the fusion reactions of wt
SFV and srf-3. Taken together, our results suggest that
srf-3 fusion and E1 conformational changes show a
significant decrease in their cholesterol requirements, whereas the
srf-3 sphingolipid requirements and overall fusion
properties are unaltered.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 7.
Sphingolipid dependence of E1 homotrimer formation in wt
SFV and srf-3. [35S]methionine- and
[35S]cysteine-labeled wt SFV or srf-3 was
mixed with sterol-free liposomes with or without sphingolipid, treated
at pH 5.8 for various times at 20°C, and analyzed by SDS-PAGE as in
Fig. 6. Homotrimeric E1 was plotted as the ratio of homotrimer obtained
without sphingolipid compared to that with sphingolipid. The graph
represents the average of two experiments.
|
|
 |
DISCUSSION |
The isolation of the srf-3 mutant and of its previous
characterization were dependent on a cholesterol-depleted mosquito cell culture system (45, 53). Published studies of cholesterol requirements in insect cells demonstrate that insects are sterol auxotrophs (41) and that, surprisingly, although insects
require cholesterol for proper development, insect cells in tissue
culture can be maintained in the absence of sterol for indefinite
periods (45, 48, 49). The overall phospholipid composition
and fatty acyl chain composition of such sterol-depleted insect cells
do not appear significantly altered (49). Thus, these
studies indicate that at least some eukaryotic cells do not require
bulk sterol to form functional membranes. Although the absence of
cholesterol or compensatory sterol in depleted insect cells is clear
(36, 45, 49), a number of issues about the lipid composition
and membrane functions of such cells remain, and these complicated the
previous interpretation of the srf-3 mutant phenotype.
First, it is now known that efficient SFV fusion requires not only
cholesterol but also sphingolipid (38, 42). Second, under
some conditions, sterol-depleted cells can adapt by an unknown
mechanism to become more susceptible to SFV infection, suggesting that
the membrane lipid composition could play a role in altering the
permissiveness of a sterol-depleted membrane (36). Lastly,
the original analysis of sterol-depleted cells did not address their
membrane sphingolipid composition or distribution (10, 49).
Thus, although clearly the srf-3 phenotype is dramatically
dependent on cholesterol in depleted versus control insect cells, this
phenotype could be due to secondary alterations in the depleted cell
membrane, which might involve lipid composition, lipid distribution, or
protein alterations. We began these studies to determine the lipid
requirement of the srf-3 mutant under controlled in vitro
conditions and to examine the function of the E1 protein carrying the
critical P226S mutation. Our results demonstrated that the key
alteration in srf-3 fusion properties was a specific
increase in the fusion of the virus with cholesterol-depleted
membranes. The sphingolipid requirement for fusion was maintained in
the srf-3 mutant and was similar to that of wt virus. The
decrease in the cholesterol requirement for srf-3 fusion
correlated with a decrease in the cholesterol requirement for the
srf-3 E1 conformational changes at low pH, detected as
exposure of an acid-specific epitope and formation of the E1
homotrimer. Thus, even though the isolation of srf-3 was
dependent on sterol-depleted insect cells, its phenotype of relative
sterol independence could be demonstrated using purified, protein-free
liposomes in vitro. Significantly, these results provide an important
functional connection between the cholesterol dependence of E1
conformational changes and the cholesterol dependence of SFV fusion.
The data presented here have identified two points in the
srf-3 E1 conformational changes that have a decreased
dependence on cholesterol: acid-specific epitope exposure and
homotrimerization. In support of these being independent steps in
fusion, previous studies indicate that acid-specific epitope exposure
can occur in a virus fusion peptide mutant that does not form the E1
homotrimer (28). In addition, studies of the binding site
for MAb E1a-1, the acid conformation-specific MAb analyzed here, mapped
this epitope to position 157 on E1 and indicate that its exposure can be triggered under conditions in which the E1 homotrimer is not formed
(1). Thus, the available evidence suggests that epitope exposure and E1 homotrimerization represent two distinct steps in the
virus fusion reaction, each of which is less cholesterol dependent in
srf-3. The simplest explanation for the relative cholesterol
independence of both steps is that both these E1 conformational changes
occur subsequent to a point that controls the sterol dependence of
fusion, a point that is less cholesterol dependent in srf-3. Previous data suggest that E1 may have a "lipid-sensing" step that
occurs prior to epitope exposure, homotrimerization, fusion peptide
insertion, and fusion (26). One example of such a potential E1 lipid-sensing function is that the kinetics of E1 epitope exposure and homotrimerization are both strongly enhanced by the presence of
sphingolipid when a cholesterol-free target membrane is assayed (14) (Fig. 7). Such cholesterol-free target membranes are
negative for both fusion peptide insertion and fusion (9, 26,
32), but the presence or absence of sphingolipid in the membrane
nevertheless affects the conformational changes in E1. One model for
SFV fusion could be that upon exposure to low pH, the E1-E2 dimer
dissociates and the E1 protein senses the target membrane lipid
composition and goes through a cholesterol-dependent priming reaction.
The primed conformation of E1 then undergoes epitope exposure,
homotrimerization, and fusion peptide insertion and finally triggers
fusion. This model suggests that once E1 is in the primed
configuration, the later conformational changes, fusion peptide
insertion, and fusion itself would not require additional cholesterol
interactions. This would be in keeping with the evidence presented here
suggesting that the overall fusion reaction of srf-3, its
activation energy, kinetics, and pH dependence, were all similar to
those of wt virus. In this model, only the formation of primed E1, a
key cholesterol-dependent step, would be altered in the
srf-3 mutant. The decreased sterol dependence of this step
in srf-3 would then lead to decreased sterol dependence of
epitope exposure, homotrimerization, and fusion. It is possible that
one of the E1 sterol-dependent conformational changes detected here
actually represents the formation of this primed intermediate and would
occur prior to the remaining E1 conformational changes and control
their sterol dependence. Our data also do not indicate whether
cholesterol could play a further role with E1 during the terminal
stages of fusion including the formation of the fusion pore.
Studies of SFV and SIN indicate that both have strongly
cholesterol-dependent fusion reactions (26, 29, 35, 45, 53, 55). Since these two alphaviruses are only distantly related, the
data suggest that highly cholesterol-dependent fusion and infection may
be a general characteristic of alphaviruses. It is not clear why
alphaviruses have evolved such a sterol-requiring fusion mechanism.
Studies of srf-3 infection by direct intrathoracic injection
into the mosquito vector show that the mutant with reduced sterol
requirement is not selected against in the insect host and, indeed, has
something of a growth advantage compared to wt virus (2). It
is possible that highly sterol-dependent viruses are selected in vivo
by transmission conditions that are not replicated in the various
tissue culture systems that we have characterized. It is also notable
that the alphavirus mutants so far characterized, although
demonstrating increased fusion with sterol-depleted membranes, all show
maximal fusion activity only with a cholesterol-containing membrane.
This result suggests that cholesterol may be an intrinsic part of
efficient alphavirus fusion, perhaps conferred by a specific priming
step during the fusogenic conformational changes in E1.
It is of interest to consider the general importance of specific lipids
in the fusion and infection of other enveloped viruses. Virus membrane
fusion can be triggered by a variety of mechanisms, including mildly
acidic pH, spike protein receptor binding (23), and dual
interaction of the virus spike protein with a receptor and coreceptor
molecule (8, 18). For many viruses, the potential role of
specific lipids in fusion has not been evaluated. This is in part
because viruses whose fusion is triggered by mechanisms involving
interactions with protein receptors and/or coreceptors are more
difficult to study with defined liposome systems (26). It is
clear that the low-pH-dependent viruses influenza virus and vesicular
stomatitis virus do not require specific lipids for membrane fusion
(13, 17, 45, 50, 56). There are several examples of viruses
with potential requirements for cholesterol in fusion and/or budding,
although clearly the data obtained with these systems are not
conclusive at this point (see reference 26 for a
review and in-depth discussion). One example is that of human
immunodeficiency virus (HIV), which may exit from regions of the plasma
membrane that are enriched in cholesterol and sphingolipid (3,
4). Studies with the N-terminal fusion peptide of HIV gp41 also
suggest that cholesterol may play a role in HIV fusion (43,
44), although these studies examine the fusion peptide out of the
normal context of the intact virus envelope protein and its
physiological fusion trigger of receptor and coreceptor (26). Studies of the coronavirus mouse hepatitis virus
suggest that susceptibility to a lytic virus infection and generation of virus-induced syncytia may be influenced by cellular cholesterol content (11, 16). Infection and fusion of African swine
fever virus are affected by cellular cholesterol content
(7), although the restricted host range of this virus of
necessity required that these studies be performed in mammalian cells
in which cholesterol depletion is limited and may produce toxic effects
(26). A variety of in vitro studies suggested that Sendai
virus, a paramyxovirus, fuses its membrane in a cholesterol-dependent
mechanism (6, 12, 24, 33). For these and other viruses, as
well as for cellular fusion proteins, the involvement of cholesterol
and other specific lipids remains an important but unresolved issue in
our understanding of the fusion reaction (26).
The E1 P226S mutation in srf-3 confers a strong increase in
the cholesterol independence of virus fusion and E1 conformational changes. Using several different selection strategies, this mutation has been independently isolated eight times (P. K. Chatterjee and
M. Kielian, unpublished data), demonstrating the overall importance of
this residue and region in SFV cholesterol interactions. Further understanding of the role of cholesterol in SFV fusion will come from
mutagenesis studies of the E1 226 region and from the isolation and
characterization of new srf mutants. It will be important to
determine if other srf mutations act by similar mechanisms to srf-3 and whether the distinct E1 regions identified as
important in the cholesterol requirement actually interact in the
three-dimensional structure of the SFV spike protein. Ongoing studies
on the structure of the srf-3 virus particle and the
properties of the srf-3 fusion pore may also add to our
understanding of the means by which the virus takes advantage of the
cholesterol present in cell plasma membranes to trigger efficient
fusion and infection.
 |
ACKNOWLEDGMENTS |
We thank Jan Wilschut for generously sharing unpublished
data on the cholesterol and sphingolipid dependence of the SFV E1 conformational changes, and we thank Jan Wilschut and Yolande Smit for
their very helpful advice and protocols for the preparation and use of
pyrene-labeled SFV in fusion assays. We thank Philip Aisen for the
generous use of his fluorometer. We also thank the members of our
laboratory for helpful discussions and suggestions, and we thank Duncan
Wilson and the members of our laboratory for critical reading of the manuscript.
This work was supported by a grant to M.K. from the National Institutes
of Health (R01 GM57454), by the Jack K. and Helen B. Lazar Fellowship
in Cell Biology, and by Cancer Center Core Support Grant NIH/NCI
P30-CA13330. M.V. was supported by a Martin Foundation Fellowship
during a portion of this work.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park
Ave., Bronx, NY 10461. Phone: (718) 430-3638. Fax: (718) 430-8574. E-mail: kielian{at}aecom.yu.edu.
 |
REFERENCES |
| 1.
|
Ahn, A.,
M. R. Klimjack,
P. K. Chatterjee, and M. Kielian.
1999.
An epitope of the Semliki Forest virus fusion protein exposed during virus-membrane fusion.
J. Virol.
73:10029-10039[Abstract/Free Full Text].
|
| 2.
|
Ahn, A.,
R. J. Schoepp,
D. Sternberg, and M. Kielian.
1999.
Growth and stability of a cholesterol-independent Semliki Forest virus mutant in mosquitoes.
Virology
262:452-456[CrossRef][Medline].
|
| 3.
|
Aloia, R. C.,
F. C. Jensen,
C. C. Curtain,
P. W. Mobley, and L. M. Gordon.
1988.
Lipid composition and fluidity of the human immunodeficiency virus.
Proc. Natl. Acad. Sci. USA
85:900-904[Abstract/Free Full Text].
|
| 4.
|
Aloia, R. C.,
H. Tian, and F. C. Jensen.
1993.
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.
Proc. Natl. Acad. Sci. USA
90:5181-5185[Abstract/Free Full Text].
|
| 5.
|
Anderson, R. G. W.
1998.
The caveolae membrane system.
Annu. Rev. Biochem.
67:199-225[CrossRef][Medline].
|
| 6.
|
Asano, K., and A. Asano.
1988.
Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F-glycoprotein of HVJ (Sendai virus): possible implication in the fusion reaction.
Biochemistry
27:1321-1329[CrossRef][Medline].
|
| 7.
|
Bernardes, C.,
A. António,
M. C. P. De Lima, and M. L. Valdeira.
1998.
Cholesterol affects African swine fever virus infection.
Biochim. Biophys. Acta
1393:19-25[Medline].
|
| 8.
|
Binley, J., and J. P. Moore.
1997.
HIV-cell fusion: the viral mousetrap.
Nature
387:346-348[CrossRef][Medline].
|
| 9.
|
Bron, R.,
J. M. Wahlberg,
H. Garoff, and J. Wilschut.
1993.
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein.
EMBO J.
12:693-701[Medline].
|
| 10.
|
Brown, K.,
C. M. Havel, and J. A. Watson.
1983.
Isoprene synthesis in isolated embryonic Drosophila cells. II. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
J. Biol. Chem.
13:8512-8518.
|
| 11.
|
Cervin, M., and R. Anderson.
1991.
Modulation of coronavirus-mediated cell fusion by homeostatic control of cholesterol and fatty acid metabolism.
J. Med. Virol.
35:142-149[Medline].
|
| 12.
|
Citovsky, V.,
S. Rottem,
O. Nussbaum,
Y. Laster,
R. Rott, and A. Loyter.
1988.
Animal viruses are able to fuse with prokaryotic cells.
J. Biol. Chem.
263:461-467[Abstract/Free Full Text].
|
| 13.
|
Cleverley, D. Z.,
H. M. Geller, and J. Lenard.
1997.
Characterization of cholesterol-free insect cells infectible by baculoviruses: Effects of cholesterol on VSV fusion and infectivity and on cytotoxicity induced by influenza M2 protein.
Exp. Cell Res.
233:288-296[CrossRef][Medline].
|
| 14.
|
Corver, J.
1998.
Membrane fusion activity of Semliki Forest virus. Ph.D. thesis.
Groningen University.
|
| 15.
|
Corver, J.,
R. Bron,
H. Snippe,
C. Kraaijeveld, and J. Wilschut.
1997.
Membrane fusion activity of Semliki forest virus in a liposomal model system: specific inhibition by Zn2+ ions.
Virology
238:14-21[CrossRef][Medline].
|
| 16.
|
Daya, M.,
M. Cervin, and R. Anderson.
1988.
Cholesterol enhances mouse hepatitis virus-mediated cell fusion.
Virology
163:276-283[CrossRef][Medline].
|
| 17.
|
Eidelman, O.,
R. Schlegel,
T. S. Tralka, and R. Blumenthal.
1984.
pH-dependent fusion induced by Vesicular Stomatitis virus glycoprotein reconstituted into phospholipid vesicles.
J. Biol. Chem.
259:4622-4628[Abstract/Free Full Text].
|
| 18.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 19.
|
Garoff, H.,
J. Wilschut,
P. Liljeström,
J. M. Wahlberg,
R. Bron,
M. Suomalainen,
J. Smyth,
A. Salminen,
B. U. Barth, and H. Zhao.
1994.
Assembly and entry mechanisms of Semliki Forest virus.
Arch. Virol.
9:329-338.
|
| 20.
|
Glomb-Reinmund, S., and M. Kielian.
1998.
fus-1, a pH-shift mutant of Semliki Forest virus, acts by altering spike subunit interactions via a mutation in the E2 subunit.
J. Virol.
72:4281-4287[Abstract/Free Full Text].
|
| 21.
|
Glomb-Reinmund, S., and M. Kielian.
1998.
The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus.
Virology
248:372-381[CrossRef][Medline].
|
| 22.
|
Hernandez, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Dev. Biol.
12:627-661[CrossRef][Medline].
|
| 23.
|
Hernandez, L. D.,
R. J. Peters,
S. E. Delos,
J. A. T. Young,
D. A. Agard, and J. M. White.
1997.
Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
J. Cell Biol.
139:1455-1464[Abstract/Free Full Text].
|
| 24.
|
Hsu, M. C.,
A. Scheid, and P. W. Choppin.
1983.
Fusion of Sendai virus with liposomes: dependence on the viral fusion protein (F) and the lipid composition of liposomes.
Virology
126:361-369[CrossRef][Medline].
|
| 25.
|
Kielian, M.
1995.
Membrane fusion and the alphavirus life cycle.
Adv. Virus Res.
45:113-151[Medline].
|
| 26.
| Kielian, M., P. K. Chatterjee, D. L. Gibbons,
and Y. E. Lu. Specific roles for lipids in virus fusion
and exit: examples from the alphaviruses. Subcell. Biochem., in press.
|
| 27.
|
Kielian, M.,
S. Jungerwirth,
K. U. Sayad, and S. DeCandido.
1990.
Biosynthesis, maturation, and acid-activation of the Semliki Forest virus fusion protein.
J. Virol.
64:4614-4624[Abstract/Free Full Text].
|
| 28.
|
Kielian, M.,
M. R. Klimjack,
S. Ghosh, and W. A. Duffus.
1996.
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.
J. Cell Biol.
134:863-872[Abstract/Free Full Text].
|
| 29.
|
Kielian, M. C., and A. Helenius.
1984.
The role of cholesterol in the fusion of Semliki Forest virus with membranes.
J. Virol.
52:281-283[Abstract/Free Full Text].
|
| 30.
|
Kielian, M. C.,
S. Keränen,
L. Kääriäinen, and A. Helenius.
1984.
Membrane fusion mutants of Semliki Forest virus.
J. Cell Biol.
98:139-145[Abstract/Free Full Text].
|
| 31.
|
Kielian, M. C.,
M. Marsh, and A. Helenius.
1986.
Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus.
EMBO J.
5:3103-3109[Medline].
|
| 32.
|
Klimjack, M. R.,
S. Jeffrey, and M. Kielian.
1994.
Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein.
J. Virol.
68:6940-6946[Abstract/Free Full Text].
|
| 33.
|
Kundrot, C. E.,
E. A. Spangler,
D. A. Kendall,
R. C. MacDonald, and R. I. MacDonald.
1983.
Sendai virus-mediated lysis of liposomes requires cholesterol.
Proc. Natl. Acad. Sci. USA
80:1608-1612[Abstract/Free Full Text].
|
| 34.
|
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 35.
|
Lu, Y. E.,
T. Cassese, and M. Kielian.
1999.
The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence.
J. Virol.
73:4272-4278[Abstract/Free Full Text].
|
| 36.
|
Marquardt, M. T., and M. Kielian.
1996.
Cholesterol-depleted cells that are relatively permissive for Semliki Forest virus infection.
Virology
224:198-205[CrossRef][Medline].
|
| 37.
|
Marquardt, M. T.,
T. Phalen, and M. Kielian.
1993.
Cholesterol is required in the exit pathway of Semliki Forest virus.
J. Cell Biol.
123:57-65[Abstract/Free Full Text].
|
| 38.
|
Moesby, L.,
J. Corver,
R. K. Erukulla,
R. Bittman, and J. Wilschut.
1995.
Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner.
Biochemistry
34:10319-10324[CrossRef][Medline].
|
| 39.
|
Morrison, W. R.
1964.
A fast, simple, and reliable method for the microdetermination of phosphorus in biological materials.
Anal. Biochem.
7:218-224.
|
| 40.
|
Nes, W. R., and M. L. McKean (ed.).
1977.
Biochemistry of steroids and other isopentenoids.
University Park Press, Baltimore, Md.
|
| 41.
|
Nes, W. R., and M. L. McKean.
1977.
Occurence, physiology, and ecology of sterols, p. 411-533.
In
W. R. Nes, and M. L. McKean (ed.), Biochemistry of steroids and other isopentenoids. University Park Press, Baltimore, Md.
|
| 42.
|
Nieva, J. L.,
R. Bron,
J. Corver, and J. Wilschut.
1994.
Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane.
EMBO J.
13:2797-2804[Medline].
|
| 43.
|
Pereira, F. B.,
F. M. Goni,
A. Muga, and J. L. Nieva.
1997.
Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Biophys. J.
73:1977-1986[Medline].
|
| 44.
|
Pereira, F. B.,
F. M. Goni, and J. L. Nieva.
1997.
Membrane fusion induced by the HIV type 1 fusion peptide: modulation of factors affecting glycoprotein 41 activity and potential anti-HIV compounds.
AIDS Res. Hum. Retroviruses
13:1203-1211[Medline].
|
| 45.
|
Phalen, T., and M. Kielian.
1991.
Cholesterol is required for infection by Semliki Forest virus.
J. Cell Biol.
112:615-623[Abstract/Free Full Text].
|
| 46.
|
Porter, J. A.,
K. E. Young, and P. A. Beachy.
1996.
Cholesterol modification of hedgehog signaling proteins in animal development.
Science
274:255-259[Abstract/Free Full Text].
|
| 47.
|
Rodal, S. D.,
G. Skretting,
O. Garred,
F. Vilhardt,
B. van Deurs, and K. Sandvig.
1999.
Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formtaiotn of clathrin-coated vesicles.
Mol. Biol. Cell
10:961-974[Abstract/Free Full Text].
|
| 48.
|
Rolls, M. M.,
M. T. Marquardt,
M. Kielian, and C. E. Machamer.
1997.
Cholesterol-independent targeting of Golgi membrane proteins in insect cells.
Mol. Biol. Cell
8:2111-2118[Abstract/Free Full Text].
|
| 49.
|
Silberkang, M.,
C. M. Havel,
D. S. Friend,
B. J. McCarthy, and J. A. Watson.
1983.
Isoprene synthesis in isolated embryonic Drosophila cells. I. Sterol-deficient eukaryotic cells.
J. Biol. Chem.
258:8303-8311.
|
| 50.
|
Stegmann, T., and A. Helenius.
1993.
Influenza virus fusion: from models towards a mechanism, p. 89-111.
In
J. Bentz (ed.), Viral fusion mechanisms. CRC Press, Inc., Boca Raton, Fla.
|
| 51.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 52.
|
Subtil, A.,
I. Gaidarov,
K. Kobylarz,
M. A. Lampson,
J. H. Keen, and T. E. McGraw.
1999.
Acute cholesterol depletion inhibits clathrin-coated pit budding.
Proc. Natl. Acad. Sci. USA
96:6775-6780[Abstract/Free Full Text].
|
| 53.
|
Vashishtha, M.,
T. Phalen,
M. T. Marquardt,
J. S. Ryu,
A. C. Ng, and M. Kielian.
1998.
A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit.
J. Cell Biol.
140:91-99[Abstract/Free Full Text].
|
| 54.
|
Wahlberg, J. M.,
R. Bron,
J. Wilschut, and H. Garoff.
1992.
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.
J. Virol.
66:7309-7318[Abstract/Free Full Text].
|
| 55.
|
White, J., and A. Helenius.
1980.
pH-dependent fusion between the Semliki Forest virus membrane and liposomes.
Proc. Natl. Acad. Sci. USA
77:3273-3277[Abstract/Free Full Text].
|
| 56.
|
White, J.,
J. Kartenbeck, and A. Helenius.
1982.
Membrane fusion activity of influenza virus.
EMBO J.
1:217-222[Medline].
|
| 57.
|
Yeagle, P. L.
1991.
Modulation of membrane function by cholesterol.
Biochimie
73:1303-1310[Medline].
|
Journal of Virology, February 2000, p. 1623-1631, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Umashankar, M., Sanchez-San Martin, C., Liao, M., Reilly, B., Guo, A., Taylor, G., Kielian, M.
(2008). Differential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion Properties. J. Virol.
82: 9245-9253
[Abstract]
[Full Text]
-
Liao, M., Kielian, M.
(2006). Site-Directed Antibodies against the Stem Region Reveal Low pH-Induced Conformational Changes of the Semliki Forest Virus Fusion Protein. J. Virol.
80: 9599-9607
[Abstract]
[Full Text]
-
Chanel-Vos, C., Kielian, M.
(2006). Second-Site Revertants of a Semliki Forest Virus Fusion-Block Mutation Reveal the Dynamics of a Class II Membrane Fusion Protein.. J. Virol.
80: 6115-6122
[Abstract]
[Full Text]
-
Markosyan, R. M., Cohen, F. S., Melikyan, G. B.
(2005). Time-resolved Imaging of HIV-1 Env-mediated Lipid and Content Mixing between a Single Virion and Cell Membrane. Mol. Biol. Cell
16: 5502-5513
[Abstract]
[Full Text]
-
Chanel-Vos, C., Kielian, M.
(2004). A Conserved Histidine in the ij Loop of the Semliki Forest Virus E1 Protein Plays an Important Role in Membrane Fusion. J. Virol.
78: 13543-13552
[Abstract]
[Full Text]
-
Gibbons, D. L., Ahn, A., Liao, M., Hammar, L., Cheng, R. H., Kielian, M.
(2004). Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus. J. Virol.
78: 3312-3318
[Abstract]
[Full Text]
-
Gibbons, D. L., Reilly, B., Ahn, A., Vaney, M.-C., Vigouroux, A., Rey, F. A., Kielian, M.
(2004). Purification and Crystallization Reveal Two Types of Interactions of the Fusion Protein Homotrimer of Semliki Forest Virus. J. Virol.
78: 3514-3523
[Abstract]
[Full Text]
-
Stiasny, K., Koessl, C., Heinz, F. X.
(2003). Involvement of Lipids in Different Steps of the Flavivirus Fusion Mechanism. J. Virol.
77: 7856-7862
[Abstract]
[Full Text]
-
Hammar, L., Markarian, S., Haag, L., Lankinen, H., Salmi, A., Cheng, R. H.
(2003). Prefusion Rearrangements Resulting in Fusion Peptide Exposure in Semliki Forest Virus. J. Biol. Chem.
278: 7189-7198
[Abstract]
[Full Text]
-
Samsonov, A. V., Chatterjee, P. K., Razinkov, V. I., Eng, C. H., Kielian, M., Cohen, F. S.
(2002). Effects of Membrane Potential and Sphingolipid Structures on Fusion of Semliki Forest Virus. J. Virol.
76: 12691-12702
[Abstract]
[Full Text]
-
Chatterjee, P. K., Eng, C. H., Kielian, M.
(2002). Novel Mutations That Control the Sphingolipid and Cholesterol Dependence of the Semliki Forest Virus Fusion Protein. J. Virol.
76: 12712-12722
[Abstract]
[Full Text]
-
Lu, X., Xiong, Y., Silver, J.
(2002). Asymmetric Requirement for Cholesterol in Receptor-Bearing but Not Envelope-Bearing Membranes for Fusion Mediated by Ecotropic Murine Leukemia Virus. J. Virol.
76: 6701-6709
[Abstract]
[Full Text]
-
Ahn, A., Gibbons, D. L., Kielian, M.
(2002). The Fusion Peptide of Semliki Forest Virus Associates with Sterol-Rich Membrane Domains. J. Virol.
76: 3267-3275
[Abstract]
[Full Text]
-
Gibbons, D. L., Kielian, M.
(2002). Molecular Dissection of the Semliki Forest Virus Homotrimer Reveals Two Functionally Distinct Regions of the Fusion Protein. J. Virol.
76: 1194-1205
[Abstract]
[Full Text]
-
Lu, Y. E., Eng, C. H., Shome, S. G., Kielian, M.
(2001). In Vivo Generation and Characterization of a Soluble Form of the Semliki Forest Virus Fusion Protein. J. Virol.
75: 8329-8339
[Abstract]
[Full Text]
-
Lu, Y. E., Kielian, M.
(2000). Semliki Forest Virus Budding: Assay, Mechanisms, and Cholesterol Requirement. J. Virol.
74: 7708-7719
[Abstract]
[Full Text]
-
Gibbons, D. L., Ahn, A., Chatterjee, P. K., Kielian, M.
(2000). Formation and Characterization of the Trimeric Form of the Fusion Protein of Semliki Forest Virus. J. Virol.
74: 7772-7780
[Abstract]
[Full Text]
-
Wang, Y.-X., Kauffman, E. J., Duex, J. E., Weisman, L. S.
(2001). Fusion of Docked Membranes Requires the Armadillo Repeat Protein Vac8p. J. Biol. Chem.
276: 35133-35140
[Abstract]
[Full Text]